文献速递生殖医学

含滑面内质网聚集卵母细胞来源囊胚行IVF或ICSI的临床结局

Clinical outcomes after IVF or ICSI using human blastocysts derived from oocytes containing aggregates of smooth endoplasmic reticulum.
PubMed 文献 · Reprod Biomed Online · 2017-01-25

本研究比较含滑面内质网(SER)聚集的卵母细胞来源囊胚在IVF与ICSI周期中的临床及新生儿结局。SER+MII卵母细胞在两种授精方式下的受精、卵裂和囊胚率无显著差异,冻融囊胚移植临床妊娠率亦无显著差异;SER+来源囊胚移植获15名新生儿(IVF 5名、ICSI 10名)且无畸形,SER-来源囊胚移植获55名新生儿(IVF 24名、ICSI 31名)。结论认为两种授精方式下SER+MII来源囊胚均获得可接受的持续妊娠率,新生儿结局与SER-MII无差异。

要点

  • SER+MII卵母细胞在IVF与ICSI间的受精、卵裂和囊胚率无显著差异。
  • 冻融囊胚移植中SER+MII来源囊胚的临床妊娠率在IVF与ICSI间无显著差异。
  • SER+来源囊胚移植获15名新生儿(IVF 5名、ICSI 10名)且无畸形。

核心结论

  • SER+MII来源囊胚在IVF和ICSI周期中均获得可接受的持续妊娠率,新生儿结局与SER-MII无差异。

研究设计与样本

  • 比较含SER聚集卵母细胞来源囊胚在IVF与ICSI周期中临床及新生儿结局的研究。

主要发现

  • SER+MII培养至第5/6天时,IVF与ICSI的受精率、卵裂率和囊胚率无显著差异。
  • 冻融囊胚移植周期中,SER+MII来源囊胚的临床妊娠率在IVF与ICSI间无显著差异。
  • 共移植52枚SER+MII来源囊胚(IVF 27枚、ICSI 25枚),获15名新生儿(IVF 5名、ICSI 10名),无畸形。
  • 共移植300枚SER-MII来源囊胚(IVF 175枚、ICSI 125枚),获55名新生儿(IVF 24名、ICSI 31名)。
  • SER+周期在IVF(n=125)或ICSI(n=117)周期后的持续妊娠率可接受。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this study the clinical and neo-natal outcomes after transfer of blastocysts derived from oocytes containing aggregates of smooth endoplasmic reticulum (SER) were compared between IVF and intracytoplasmic sperm injection (ICSI) cycles. Clinical and neo-natal outcomes of blastocysts in cycles with at least one SER metaphase II oocyte (SER + MII; SER + cycles) did not significantly differ between the two insemination methods. When SER + MII were cultured to day 5/6, fertilization, embryo cleavage and blastocyst rates were not significantly different between IVF and ICSI cycles. In vitrified-warmed blastocyst transfer cycles, the clinical pregnancy rates from SER + MII in IVF and ICSI did not significantly differ. In this study, 52 blastocysts (27 IVF and 25 ICSI) derived from SER + MII were transferred, yielding 15 newborns (5 IVF and 10 ICSI) and no malformations. Moreover, 300 blastocysts (175 IVF and 125 ICSI) derived from SER-MII were transferred, yielding 55 newborns (24 IVF and 31 ICSI cycles). Thus, blastocysts derived from SER + cycles exhibited an acceptable ongoing pregnancy rate after IVF (n = 125) or ICSI (n = 117) cycles. In conclusion, blastocysts from SER + MII in both IVF and ICSI cycles yield adequate ongoing pregnancy rates with neo-natal outcomes that do not differ from SER-MII.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Itoi F, Asano Y, Shimizu M, et al. Clinical outcomes after IVF or ICSI using human blastocysts derived from oocytes containing aggregates of smooth endoplasmic reticulum. Reprod Biomed Online. 2017. PMID: 28169188. doi:10.1016/j.rbmo.2017.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。